Industry-chain Research Brief

Shang Hai Sheng Nong Pesticide. Co., Ltd.: Biomedicine and medical devices Little Giant Industry Chain Brief

Shanghai · Biomedicine and medical devices · 2026-06-12

English company profile Full Chinese report All report summaries

English Summary

Shang Hai Sheng Nong Pesticide. Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Shanghai. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-12. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyShang Hai Sheng Nong Pesticide. Co., Ltd.
RegionShanghai
IndustryBiomedicine and medical devices
Published2026-06-12
Chinese reportOpen
CompanyShang Hai Sheng Nong Pesticide. Co., Ltd.
Region / IndustryShanghai · Biomedicine and medical devices
Recognition2020 2nd batch
Patent signal155 patent-related records

Company and Recognition Snapshot

Shang Hai Sheng Nong Pesticide. Co., Ltd. is indexed as a national-level Little Giant enterprise in Shanghai. The English profile places the company under Biomedicine and medical devices and records 2020 2nd batch as the available recognition context.

Recognition batch2020 2nd batch
RegionShanghai
IndustryBiomedicine and medical devices
Registered capitalRMB 68.74 million
Employee signal187 employees
Listed statusNot listed
Patent signal155 patent-related records
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Chinese public records indicate environmental-protection and resource-recycling activity, R&D, design and engineering activity. The recorded industry-chain position is Biomedicine and medical devices / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records 155 patent-related records. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths